Cargando…
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients
Background: COVID-19 is a heterogenous disease resulting in long-term sequela in predisposed individuals. It is not uncommon that recovering patients endure non-respiratory ill-defined manifestations, including anosmia, and neurological and cognitive deficit persisting beyond recovery—a constellatio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955917/ https://www.ncbi.nlm.nih.gov/pubmed/36832180 http://dx.doi.org/10.3390/diagnostics13040687 |
_version_ | 1784894464881328128 |
---|---|
author | Lavi, Yael Vojdani, Aristo Halpert, Gilad Sharif, Kassem Ostrinski, Yuri Zyskind, Israel Lattin, Miriam T Zimmerman, Jason Silverberg, Jonathan I Rosenberg, Avi Z Shoenfeld, Yehuda Amital, Howard |
author_facet | Lavi, Yael Vojdani, Aristo Halpert, Gilad Sharif, Kassem Ostrinski, Yuri Zyskind, Israel Lattin, Miriam T Zimmerman, Jason Silverberg, Jonathan I Rosenberg, Avi Z Shoenfeld, Yehuda Amital, Howard |
author_sort | Lavi, Yael |
collection | PubMed |
description | Background: COVID-19 is a heterogenous disease resulting in long-term sequela in predisposed individuals. It is not uncommon that recovering patients endure non-respiratory ill-defined manifestations, including anosmia, and neurological and cognitive deficit persisting beyond recovery—a constellation of conditions that are grouped under the umbrella of long-term COVID-19 syndrome. Association between COVID-19 and autoimmune responses in predisposed individuals was shown in several studies. Aim and methods: To investigate autoimmune responses against neuronal and CNS autoantigens in SARS-CoV-2-infected patients, we performed a cross-sectional study with 246 participants, including 169 COVID-19 patients and 77 controls. Levels of antibodies against the acetylcholine receptor, glutamate receptor, amyloid β peptide, alpha-synucleins, dopamine 1 receptor, dopamine 2 receptor, tau protein, GAD-65, N-methyl D-aspartate (NMDA) receptor, BDNF, cerebellar, ganglioside, myelin basic protein, myelin oligodendrocyte glycoprotein, S100-B, glial fibrillary acidic protein, and enteric nerve were measured using an Enzyme-Linked Immunosorbent Assay (ELISA). Circulating levels of autoantibodies were compared between healthy controls and COVID-19 patients and then classified by disease severity (mild [n = 74], severe [n = 65], and requiring supplemental oxygen [n = 32]). Results: COVID-19 patients were found to have dysregulated autoantibody levels correlating with the disease severity, e.g., IgG to dopamine 1 receptor, NMDA receptors, brain-derived neurotrophic factor, and myelin oligodendrocyte glycoprotein. Elevated levels of IgA autoantibodies against amyloid β peptide, acetylcholine receptor, dopamine 2 receptor, myelin basic protein, and α-synuclein were detected in COVID-19 patients compared with healthy controls. Lower IgA autoantibody levels against NMDA receptors, and IgG autoantibodies against glutamic acid decarboxylase 65, amyloid β peptide, tau protein, enteric nerve, and S100-B were detected in COVID-19 patients versus healthy controls. Some of these antibodies have known clinical correlations with symptoms commonly reported in the long COVID-19 syndrome. Conclusions: Overall, our study shows a widespread dysregulation in the titer of various autoantibodies against neuronal and CNS-related autoantigens in convalescent COVID-19 patients. Further research is needed to provide insight into the association between these neuronal autoantibodies and the enigmatic neurological and psychological symptoms reported in COVID-19 patients. |
format | Online Article Text |
id | pubmed-9955917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99559172023-02-25 Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients Lavi, Yael Vojdani, Aristo Halpert, Gilad Sharif, Kassem Ostrinski, Yuri Zyskind, Israel Lattin, Miriam T Zimmerman, Jason Silverberg, Jonathan I Rosenberg, Avi Z Shoenfeld, Yehuda Amital, Howard Diagnostics (Basel) Article Background: COVID-19 is a heterogenous disease resulting in long-term sequela in predisposed individuals. It is not uncommon that recovering patients endure non-respiratory ill-defined manifestations, including anosmia, and neurological and cognitive deficit persisting beyond recovery—a constellation of conditions that are grouped under the umbrella of long-term COVID-19 syndrome. Association between COVID-19 and autoimmune responses in predisposed individuals was shown in several studies. Aim and methods: To investigate autoimmune responses against neuronal and CNS autoantigens in SARS-CoV-2-infected patients, we performed a cross-sectional study with 246 participants, including 169 COVID-19 patients and 77 controls. Levels of antibodies against the acetylcholine receptor, glutamate receptor, amyloid β peptide, alpha-synucleins, dopamine 1 receptor, dopamine 2 receptor, tau protein, GAD-65, N-methyl D-aspartate (NMDA) receptor, BDNF, cerebellar, ganglioside, myelin basic protein, myelin oligodendrocyte glycoprotein, S100-B, glial fibrillary acidic protein, and enteric nerve were measured using an Enzyme-Linked Immunosorbent Assay (ELISA). Circulating levels of autoantibodies were compared between healthy controls and COVID-19 patients and then classified by disease severity (mild [n = 74], severe [n = 65], and requiring supplemental oxygen [n = 32]). Results: COVID-19 patients were found to have dysregulated autoantibody levels correlating with the disease severity, e.g., IgG to dopamine 1 receptor, NMDA receptors, brain-derived neurotrophic factor, and myelin oligodendrocyte glycoprotein. Elevated levels of IgA autoantibodies against amyloid β peptide, acetylcholine receptor, dopamine 2 receptor, myelin basic protein, and α-synuclein were detected in COVID-19 patients compared with healthy controls. Lower IgA autoantibody levels against NMDA receptors, and IgG autoantibodies against glutamic acid decarboxylase 65, amyloid β peptide, tau protein, enteric nerve, and S100-B were detected in COVID-19 patients versus healthy controls. Some of these antibodies have known clinical correlations with symptoms commonly reported in the long COVID-19 syndrome. Conclusions: Overall, our study shows a widespread dysregulation in the titer of various autoantibodies against neuronal and CNS-related autoantigens in convalescent COVID-19 patients. Further research is needed to provide insight into the association between these neuronal autoantibodies and the enigmatic neurological and psychological symptoms reported in COVID-19 patients. MDPI 2023-02-12 /pmc/articles/PMC9955917/ /pubmed/36832180 http://dx.doi.org/10.3390/diagnostics13040687 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lavi, Yael Vojdani, Aristo Halpert, Gilad Sharif, Kassem Ostrinski, Yuri Zyskind, Israel Lattin, Miriam T Zimmerman, Jason Silverberg, Jonathan I Rosenberg, Avi Z Shoenfeld, Yehuda Amital, Howard Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients |
title | Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients |
title_full | Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients |
title_fullStr | Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients |
title_full_unstemmed | Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients |
title_short | Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients |
title_sort | dysregulated levels of circulating autoantibodies against neuronal and nervous system autoantigens in covid-19 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955917/ https://www.ncbi.nlm.nih.gov/pubmed/36832180 http://dx.doi.org/10.3390/diagnostics13040687 |
work_keys_str_mv | AT laviyael dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT vojdaniaristo dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT halpertgilad dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT sharifkassem dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT ostrinskiyuri dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT zyskindisrael dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT lattinmiriamt dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT zimmermanjason dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT silverbergjonathani dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT rosenbergaviz dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT shoenfeldyehuda dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients AT amitalhoward dysregulatedlevelsofcirculatingautoantibodiesagainstneuronalandnervoussystemautoantigensincovid19patients |